Following the success of four editions last year, we are delighted to kick-start the 2025 tax year with the o2h chaitime portfolio pitch day — April Edition, taking place at 2:30PM on Friday, 25th April 2025. 

Our previous pitch days have proven to be an outstanding platform for early-stage biotechs - with 19 of our portfolio companies having pitched to more than 150 investors leading to significant funding and partnerships.

This event will feature presentations from the following companies:

  • Revolver Therapeutics - A University of Bath spinout developing peptide-based therapies to tackle childhood brain cancers, including aggressive gliomas.
  • Stratosvir - Developing viral immunotherapies for cancer, including enabling intravenous delivery and making it possible to dose multiple times.
  • Sansanima - Offering a validated cell-based assay alternative to animal testing for toxin-based products, already in use by global vaccine and therapeutic manufacturers.
  • Spirea - A University of Cambridge spinout, elevating the therapeutic potential of ADCs in cancer and beyond.
  • Cellestial Health (o2h Kickstarter Competition Winner) - Targeting astrocytic networks to create new therapeutic pathways for halting the progression of neurodegenerative diseases, including Parkinson’s.

Spend your friday afternoon with sharp pitches, good conversations, and a room full of like-minded people. If you are an investor or partner, drop us a note at [email protected] if you’d like to join at our HQ in Cambridge. 

Return to listing